Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manu...

FDA Recall #D-0311-2019 — Class II — November 20, 2018

Recall #D-0311-2019 Date: November 20, 2018 Classification: Class II Status: Ongoing

Product Description

Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg, 30-count bottle, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505, U.S.A., NDC 0378-1721-93.

Reason for Recall

CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.

Recalling Firm

Mylan Pharmaceuticals Inc. — Morgantown, WV

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

23,478 bottles

Distribution

Product was distributed throughout the United States.

Code Information

Lot # 3066051, exp. date 3/2019

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated